Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67.6M
-
Number of holders
-
259
-
Total 13F shares, excl. options
-
49.4M
-
Shares change
-
+2.53M
-
Total reported value, excl. options
-
$2.92B
-
Value change
-
+$146M
-
Put/Call ratio
-
0.97
-
Number of buys
-
131
-
Number of sells
-
-118
-
Price
-
$58.98
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q3 2019
322 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q3 2019.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 259 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.4M shares
of 67.6M outstanding shares and own 73.11% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.46M shares), BlackRock Inc. (4.25M shares), WELLINGTON MANAGEMENT GROUP LLP (2.07M shares), FRED ALGER MANAGEMENT, LLC (1.96M shares), FEDERATED INVESTORS INC /PA/ (1.51M shares), STATE STREET CORP (1.32M shares), RENAISSANCE TECHNOLOGIES LLC (1.29M shares), TimesSquare Capital Management, LLC (1.24M shares), Redmile Group, LLC (1.16M shares), and Consonance Capital Management LP (1.02M shares).
This table shows the top 259 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.